StonvexLoading…
StonvexStonvexStonvexCore line items from GCMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $124.78M | $557.57M | $380.47M | $245.50M |
Operating Income | $20.48M | $133.45M | $78.75M | $34.58M |
Net Income | $5.47M | $45.37M | $26.39M | $15.90M |
EPS (Diluted) | $0.06 | $0.42 | $0.23 | $0.07 |
Total Assets | $688.77M | $813.76M | $685.93M | $636.86M |
Total Liabilities | $566.50M | $686.33M | $682.11M | $657.50M |
Cash & Equivalents | $164.39M | $242.12M | $182.75M | $136.33M |
Free Cash Flow OCF − CapEx | $47.88M | $175.04M | $151.12M | $72.85M |
Shares Outstanding | 204.76M | 197.29M | 196.27M | 195.64M |